首页> 中文期刊> 《外科研究与新技术》 >The management of liver cancer with blood supply from parasitic vessels after transcatheter arterial chemoembolization

The management of liver cancer with blood supply from parasitic vessels after transcatheter arterial chemoembolization

         

摘要

Objective To study the effect of therapeutic strategies for liver cancer with blood supply from parasitic vessels after undergoing transcatheter arterial chemoembolization (TACE). Methods Forty-three liver cancer cases with parasitic arterial blood supply verified by angiography received consecutively TACE, adjuvant chemotherapy or percutaneous ethanal injection (PEI). Tumor shrinkage, patients survival,change of sIL- 2R and AFP level were observed. Results Liver cancer with parasitic arterial blood supply was all of macronodular type. Tumor shrinkage 50% after TACE plus chemotherapy was observed in 3 cases (15%). The accumulated 1,3,5 year s survial rate were 55% , 12. 2% and 0% , respectively. sIL-2R,AFP level experienced only a transient decline. Tumor shrinkage 50% was seen in 7 cases after TACE and PEI (30%),and the 1,3,5 year’s survival rate was 52 %, 35 %, and 9 % , respectively. Conclusion Adjuvant chemotherapy was hardly beneficial to the treatment of liver cancer with parasite blood

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号